Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florent Peyraud

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Cancers|June 13, 2020
Combined PARP Inhibition and Immune Checkpoint Therapy in Solid TumorsFlorent Peyraud, Antoine Italiano
Current Oncology Reports|September 7, 2017
CSF-1R Inhibitor Development: Current Clinical StatusFlorent Peyraud, Sophie Cousin, Antoine Italiano
European Urology|April 3, 2021
New Insights into Adjuvant Therapy in Renal Cell Carcinoma: Is the Chapter of VEGF Inhibitors Definitely Closed?Florent Peyraud, Mathieu Larroquette, Alain Ravaud, et al.
Frontiers in Immunology|March 21, 2022
Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast CancersCéline Blaye, Thomas Boyer, Florent Peyraud, et al.
Frontiers in Immunology|February 17, 2022
Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and PerspectivesFlorent Peyraud, Jean-Philippe Guegan, Dominique Bodet, et al.
Cancer Treatment Reviews|April 27, 2021
Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectivesMathieu Larroquette, Florent Peyraud, Charlotte Domblides, et al.
Med (New York, N.Y.)|January 11, 2025
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedsideFlorent Peyraud, Jean-Philippe Guegan, Lucile Vanhersecke, et al.
Clinical and Experimental Medicine|February 16, 2026
Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarkerSofiane Taleb, Maxime Brunet, Laila Belcaid, et al.
Cancer Treatment Reviews|August 18, 2020
Current management and future perspectives of penile cancer: An updated reviewFlorent Peyraud, Clément Allenet, Marine Gross-Goupil, et al.
Journal of Hematology & Oncology|October 24, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomasJean Philippe Guegan, Nathan El Ghazzi, Julien Vibert, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Cancers|June 13, 2020
Combined PARP Inhibition and Immune Checkpoint Therapy in Solid TumorsFlorent Peyraud, Antoine Italiano
Current Oncology Reports|September 7, 2017
CSF-1R Inhibitor Development: Current Clinical StatusFlorent Peyraud, Sophie Cousin, Antoine Italiano
European Urology|April 3, 2021
New Insights into Adjuvant Therapy in Renal Cell Carcinoma: Is the Chapter of VEGF Inhibitors Definitely Closed?Florent Peyraud, Mathieu Larroquette, Alain Ravaud, et al.
Frontiers in Immunology|March 21, 2022
Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast CancersCéline Blaye, Thomas Boyer, Florent Peyraud, et al.
Frontiers in Immunology|February 17, 2022
Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and PerspectivesFlorent Peyraud, Jean-Philippe Guegan, Dominique Bodet, et al.
Cancer Treatment Reviews|April 27, 2021
Adjuvant therapy in renal cell carcinoma: Current knowledges and future perspectivesMathieu Larroquette, Florent Peyraud, Charlotte Domblides, et al.
Med (New York, N.Y.)|January 11, 2025
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedsideFlorent Peyraud, Jean-Philippe Guegan, Lucile Vanhersecke, et al.
Clinical and Experimental Medicine|February 16, 2026
Prognostic significance of tumor fraction in advanced sarcoma: highlighting a novel circulating biomarkerSofiane Taleb, Maxime Brunet, Laila Belcaid, et al.
Cancer Treatment Reviews|August 18, 2020
Current management and future perspectives of penile cancer: An updated reviewFlorent Peyraud, Clément Allenet, Marine Gross-Goupil, et al.
Journal of Hematology & Oncology|October 24, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomasJean Philippe Guegan, Nathan El Ghazzi, Julien Vibert, et al.
Pageof 2